Lilly 4Q profit surges, helped by new COVID-19 treatment
INDIANAPOLIS - Eli Lilly's new COVID-19 treatment helped the drugmaker's fourth-quarter profit surge even though U.S. regulators approved its use late in the quarter. The antibody…
INDIANAPOLIS - Eli Lilly's new COVID-19 treatment helped the drugmaker's fourth-quarter profit surge even though U.S. regulators approved its use late in the quarter. The antibody…